Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Zonglian Medical Health Technology is a Chinese pharmaceutical company established in 2015 and based in Chengdu, Sichuan Province. Operating primarily under the Marketing Authorization Holder (MAH) system, the company focuses on the development and commercialization of generic chemical drugs. Its product portfolio includes treatments across various therapeutic areas, such as gastrointestinal disorders, hyperphosphatemia, and ophthalmic conditions. Notable pipeline products include Lanthanum carbonate chewable tablets, Esomeprazole magnesium enteric-coated capsules, and Polyvinyl alcohol eye drops. Chengdu Zonglian collaborates with established domestic manufacturers like Chengdu Tiantaishan Pharmaceutical and Taiji Group for the production and commercialization of its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Zonglian Medical Health Technology.